Winning in the Pandemic Market??

Now is a good time to be a biotech manufacturer! In what seemed a no-profits business: the vaccine industry, suddenly a ripe new investment market seems to have opened up overnight! The current killer app of the vaccine world is the 6 month turn around from pandemic flu outbreak to vaccine mass-production. Of course, no company has the capabilities to guarantee that kind of scenario at the moment, but now that the money is flooding in this is becoming a likely future reality. The real winners are the companies that can provide global cooperative strategies and make real growth in their research and development fields.

The old egg-grown operation runs into massive scalability problems when dealing with global pandemic, and new concepts need to be employed. DNA replication may pave the way, but perhaps new techniques in classical vaccine production can provide the answer sooner.